Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 3
1973 1
1975 2
1976 1
1977 4
1978 2
1980 2
1981 3
1982 2
1983 1
1985 2
1986 4
1987 3
1988 1
1991 3
1992 1
1993 4
1995 3
1996 4
1997 2
1998 2
1999 2
2000 1
2001 1
2002 2
2003 1
2004 1
2005 1
2006 1
2007 2
2008 3
2009 1
2010 2
2011 1
2012 1
2013 2
2017 2
2018 3
2019 1
2020 9
2021 5
2022 6
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Buchmann S, Schrappe M, Baruchel A, Biondi A, Borowitz M, Campbell M, Cario G, Cazzaniga G, Escherich G, Harrison CJ, Heyman M, Hunger SP, Kiss C, Liu HC, Locatelli F, Loh ML, Manabe A, Mann G, Pieters R, Pui CH, Rives S, Schmiegelow K, Silverman LB, Stary J, Vora A, Brown P. Buchmann S, et al. Blood. 2022 Mar 24;139(12):1785-1793. doi: 10.1182/blood.2021012328. Blood. 2022. PMID: 34192312 Free PMC article.
Relapse can only be defined in patients who have achieved CR and must include a specific threshold of leukemic cells in the bone marrow confirmed by MRD, the detection of central nervous system leukemia, or documentation of extramedullary disease. ...
Relapse can only be defined in patients who have achieved CR and must include a specific threshold of leukemic cells in the bone marrow conf …
Effect of Dasatinib vs Imatinib in the Treatment of Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Randomized Clinical Trial.
Shen S, Chen X, Cai J, Yu J, Gao J, Hu S, Zhai X, Liang C, Ju X, Jiang H, Jin R, Wu X, Wang N, Tian X, Pan K, Jiang H, Sun L, Fang Y, Li CK, Hu Q, Yang M, Zhu Y, Zhang H, Li C, Pei D, Jeha S, Yang JJ, Cheng C, Tang J, Zhu X, Pui CH. Shen S, et al. JAMA Oncol. 2020 Mar 1;6(3):358-366. doi: 10.1001/jamaoncol.2019.5868. JAMA Oncol. 2020. PMID: 31944221 Free PMC article. Clinical Trial.
CONCLUSIONS AND RELEVANCE: Intensive chemotherapy including dasatinib at a dosage of 80 mg/m2 per day yielded superior results in the treatment of Philadelphia chromosome-positive ALL compared with imatinib mesylate at a dosage of 300 mg/m2 per day and provided excellent control …
CONCLUSIONS AND RELEVANCE: Intensive chemotherapy including dasatinib at a dosage of 80 mg/m2 per day yielded superior results in the treatm …
Revealing the molecular mechanism of central nervous system leukemia with single-cell technology.
Zhang C, Zhong JF, Zhang X. Zhang C, et al. Crit Rev Oncol Hematol. 2020 Sep;153:103046. doi: 10.1016/j.critrevonc.2020.103046. Epub 2020 Jun 30. Crit Rev Oncol Hematol. 2020. PMID: 32650214 Review.
Central nervous system leukemia (CNSL) is a severe complication of acute leukemia, with serious consequences for life quality and expectancy. ...
Central nervous system leukemia (CNSL) is a severe complication of acute leukemia, with serious consequences for …
Multiomic Profiling of Central Nervous System Leukemia Identifies mRNA Translation as a Therapeutic Target.
Vanner RJ, Dobson SM, Gan OI, McLeod J, Schoof EM, Grandal I, Wintersinger JA, Garcia-Prat L, Hosseini M, Xie SZ, Jin L, Mbong N, Voisin V, Chan-Seng-Yue M, Kennedy JA, Waanders E, Morris Q, Porse B, Chan SM, Guidos CJ, Danska JS, Minden MD, Mullighan CG, Dick JE. Vanner RJ, et al. Blood Cancer Discov. 2022 Jan;3(1):16-31. doi: 10.1158/2643-3230.BCD-20-0216. Epub 2021 Oct 11. Blood Cancer Discov. 2022. PMID: 35019858 Free PMC article.
Acute lymphoblastic leukemia.
Miller DR. Miller DR. Pediatr Clin North Am. 1980 May;27(2):269-91. doi: 10.1016/s0031-3955(16)33851-2. Pediatr Clin North Am. 1980. PMID: 6992074 Review.
The improved outlook in childhood leukemia can be attributed to more accurate diagnosis, better supportive care, the use of drug combinations to achieve and maintain remission, and prophylactic therapy to prevent central nervous system leukemia. With t …
The improved outlook in childhood leukemia can be attributed to more accurate diagnosis, better supportive care, the use of drug combination …
Childhood and adolescent lymphoid and myeloid leukemia.
Pui CH, Schrappe M, Ribeiro RC, Niemeyer CM. Pui CH, et al. Hematology Am Soc Hematol Educ Program. 2004:118-45. doi: 10.1182/asheducation-2004.1.118. Hematology Am Soc Hematol Educ Program. 2004. PMID: 15561680 Review.
Early results suggest that minimal residual disease measurement can also improve the risk assessment in acute myeloid leukemia, and that cranial irradiation can be omitted even in those with central-nervous-system leukemia at diagnosis. In Section IV, …
Early results suggest that minimal residual disease measurement can also improve the risk assessment in acute myeloid leukemia, and that cra …
Prognostic factors for clinical outcomes of patients with central nervous system leukemia.
Bharucha J, Cao Q, Sachs Z, Smith A, Williams S, Amin K, Bachanova V, Warlick E, Brunstein C, Weisdorf D, Bejanyan N. Bharucha J, et al. Hematol Oncol Stem Cell Ther. 2021 Sep;14(3):240-245. doi: 10.1016/j.hemonc.2020.11.004. Epub 2020 Nov 24. Hematol Oncol Stem Cell Ther. 2021. PMID: 33271117 Free PMC article. Clinical Trial.
98 results